PRTK Annual Working Capital
$99.45 M
-$21.35 M-17.67%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual working capital is $99.45 million, with the most recent change of -$21.35 million (-17.67%) on December 31, 2022. During the last 3 years, it has fallen by -$119.70 million (-54.62%).PRTK Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly Working Capital
-$97.39 M
-$175.66 M-224.43%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly working capital is -$97.39 million, with the most recent change of -$175.66 million (-224.43%) on June 30, 2023. Over the past year, it has dropped by -$195.06 million (-199.72%).PRTK Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.7% | -199.7% |
| 3 y3 years | -54.6% | -151.7% |
| 5 y5 years | -30.8% | -141.6% |
PRTK Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -58.1% | -136.5% |
Paratek Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | -$97.39 M(-224.4%) |
| Mar 2023 | - | $78.27 M(-21.3%) |
| Dec 2022 | $99.45 M(-17.7%) | $99.45 M(+20.7%) |
| Sept 2022 | - | $82.36 M(-15.7%) |
| June 2022 | - | $97.67 M(-6.5%) |
| Mar 2022 | - | $104.44 M(-13.5%) |
| Dec 2021 | $120.80 M(-13.8%) | $120.80 M(-2.5%) |
| Sept 2021 | - | $123.86 M(-6.5%) |
| June 2021 | - | $132.53 M(+11.5%) |
| Mar 2021 | - | $118.87 M(-15.2%) |
| Dec 2020 | $140.16 M(-36.0%) | $140.16 M(-18.6%) |
| Sept 2020 | - | $172.10 M(-8.6%) |
| June 2020 | - | $188.28 M(+2.4%) |
| Mar 2020 | - | $183.90 M(-16.1%) |
| Dec 2019 | $219.15 M(-7.7%) | $219.15 M(-0.5%) |
| Sept 2019 | - | $220.16 M(-10.7%) |
| June 2019 | - | $246.60 M(-0.5%) |
| Mar 2019 | - | $247.86 M(+4.3%) |
| Dec 2018 | $237.53 M(+65.3%) | $237.53 M(-11.0%) |
| Sept 2018 | - | $266.83 M(+14.1%) |
| June 2018 | - | $233.90 M(+41.9%) |
| Mar 2018 | - | $164.86 M(+14.7%) |
| Dec 2017 | $143.70 M(+28.7%) | $143.70 M(-4.5%) |
| Sept 2017 | - | $150.41 M(-8.0%) |
| June 2017 | - | $163.42 M(+31.6%) |
| Mar 2017 | - | $124.16 M(+11.2%) |
| Dec 2016 | $111.69 M(-8.4%) | $111.69 M(+5.7%) |
| Sept 2016 | - | $105.71 M(-16.5%) |
| June 2016 | - | $126.64 M(+35.7%) |
| Mar 2016 | - | $93.32 M(-23.5%) |
| Dec 2015 | $121.92 M(+24.9%) | $121.92 M(-13.8%) |
| Sept 2015 | - | $141.38 M(-0.9%) |
| June 2015 | - | $142.66 M(+64.4%) |
| Mar 2015 | - | $86.76 M(-11.1%) |
| Dec 2014 | $97.59 M | $97.59 M(+185.3%) |
| Sept 2014 | - | $34.20 M(-18.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2014 | - | $41.85 M(-39.7%) |
| Mar 2014 | - | $69.43 M(-3.2%) |
| Dec 2013 | $71.70 M(-22.3%) | $71.70 M(-6.0%) |
| Sept 2013 | - | $76.24 M(-4.6%) |
| June 2013 | - | $79.89 M(-3.6%) |
| Mar 2013 | - | $82.87 M(-10.2%) |
| Dec 2012 | $92.30 M(+47.7%) | $92.30 M(-5.7%) |
| Sept 2012 | - | $97.85 M(+6.2%) |
| June 2012 | - | $92.15 M(+56.9%) |
| Mar 2012 | - | $58.74 M(-6.0%) |
| Dec 2011 | $62.50 M(+4.6%) | $62.50 M(+18.0%) |
| Sept 2011 | - | $52.97 M(-7.5%) |
| June 2011 | - | $57.27 M(-2.3%) |
| Mar 2011 | - | $58.64 M(-1.9%) |
| Dec 2010 | $59.77 M(-19.5%) | $59.77 M(-3.4%) |
| Sept 2010 | - | $61.86 M(-5.0%) |
| June 2010 | - | $65.12 M(-6.7%) |
| Mar 2010 | - | $69.77 M(-6.1%) |
| Dec 2009 | $74.29 M(+980.6%) | $74.29 M(-6.3%) |
| Sept 2009 | - | $79.28 M(+10.7%) |
| June 2009 | - | $71.60 M(-8.6%) |
| Mar 2009 | - | $78.36 M(+1039.7%) |
| Dec 2008 | $6.88 M(-92.2%) | $6.88 M(-92.0%) |
| Sept 2008 | - | $85.93 M(-6.2%) |
| June 2008 | - | $91.58 M(+108.7%) |
| Mar 2008 | - | $43.89 M(-50.5%) |
| Dec 2007 | $88.61 M(+49.1%) | $88.61 M(-4.0%) |
| Sept 2007 | - | $92.29 M(+7.4%) |
| June 2007 | - | $85.96 M(+72.3%) |
| Mar 2007 | - | $49.89 M(-16.1%) |
| Dec 2006 | $59.44 M(+26.3%) | $59.44 M(-10.4%) |
| Sept 2006 | - | $66.35 M(-8.7%) |
| June 2006 | - | $72.70 M(+86.1%) |
| Mar 2006 | - | $39.06 M(-17.0%) |
| Dec 2005 | $47.05 M(+4.8%) | $47.05 M(+4.8%) |
| Dec 2004 | $44.91 M | $44.91 M |
FAQ
- What is Paratek Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual working capital year-on-year change?
- What is Paratek Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly working capital year-on-year change?
What is Paratek Pharmaceuticals annual working capital?
The current annual working capital of PRTK is $99.45 M
What is the all time high annual working capital for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual working capital is $237.53 M
What is Paratek Pharmaceuticals annual working capital year-on-year change?
Over the past year, PRTK annual working capital has changed by -$21.35 M (-17.67%)
What is Paratek Pharmaceuticals quarterly working capital?
The current quarterly working capital of PRTK is -$97.39 M
What is the all time high quarterly working capital for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly working capital is $266.83 M
What is Paratek Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, PRTK quarterly working capital has changed by -$195.06 M (-199.72%)